WELLS FARGO & COMPANY/MN - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 5.69 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$129,000
-58.8%
26,730
-9.1%
0.00%
Q4 2019$313,000
-57.9%
29,415
-58.8%
0.00%
Q3 2019$744,000
-22.5%
71,425
+14.0%
0.00%
Q2 2019$960,000
+15.4%
62,639
-3.3%
0.00%
Q1 2019$832,000
+481.8%
64,791
+331.7%
0.00%
Q4 2018$143,000
-39.7%
15,008
+5.3%
0.00%
Q3 2018$237,000
+10.7%
14,256
+6.9%
0.00%
Q2 2018$214,000
-4.5%
13,332
-9.2%
0.00%
Q1 2018$224,000
-2.6%
14,678
-0.8%
0.00%
Q4 2017$230,000
+37.7%
14,790
-1.5%
0.00%
Q3 2017$167,000
+32.5%
15,020
+10.1%
0.00%
Q2 2017$126,000
+7.7%
13,6470.0%0.00%
Q1 2017$117,000
-16.4%
13,647
+3.8%
0.00%
Q4 2016$140,000
+66.7%
13,147
+67.8%
0.00%
Q3 2016$84,000
+58.5%
7,8340.0%0.00%
Q2 2016$53,000
+47.2%
7,834
-4.2%
0.00%
Q1 2016$36,000
-28.0%
8,179
+3.7%
0.00%
Q4 2015$50,000
-28.6%
7,889
+0.1%
0.00%
Q3 2015$70,000
-30.7%
7,885
-8.1%
0.00%
Q2 2015$101,000
+62.9%
8,583
+100.4%
0.00%
Q1 2015$62,000
+138.5%
4,282
+178.6%
0.00%
Q4 2014$26,000
+36.8%
1,537
+0.3%
0.00%
Q3 2014$19,000
-29.6%
1,533
-15.9%
0.00%
Q2 2014$27,0001,823
+60666.7%
0.00%
Q1 2014$030.0%0.00%
Q4 2013$0
-100.0%
3
-97.0%
0.00%
Q3 2013$5,0001010.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders